Your browser doesn't support javascript.
loading
Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66].
Novello, S; Torri, V; Grohe, C; Kurz, S; Serke, M; Wehler, T; Meyer, A; Ladage, D; Geissler, M; Colantonio, I; Cauchi, C; Stoelben, E; Ceribelli, A; Kropf-Sanchen, C; Valmadre, G; Borra, G; Schena, M; Morabito, A; Santo, A; Gregorc, V; Chiari, R; Reck, M; Schmid-Bindert, G; Folprecht, G; Griesinger, F; Follador, A; Pedrazzoli, P; Bearz, A; Caffo, O; Dickgreber, N J; Irtelli, L; Wiest, G; Monica, V; Porcu, L; Manegold, C; Scagliotti, G V.
Afiliación
  • Novello S; University of Torino, Department of Oncology at San Luigi Hospital, Orbassano (Torino), Italy. Electronic address: silvia.novello@unito.it.
  • Torri V; Laboratory of Methodology for Clinical Research, Oncology Department at Instituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Grohe C; Department of Respiratory Diseases, Evangelische Lungenklinik Berlin, Berlin, Germany.
  • Kurz S; Evangelische Lungenklinik Berlin, Berlin, Germany.
  • Serke M; Thorax Center Clinic for Haematology, Oncology, Pulmonology and Palliative Medicine, Evangelisches Krankenhaus Hamm, Hamm, Germany.
  • Wehler T; Thorax Center Clinic for Haematology, Oncology, Pulmonology and Palliative Medicine, Evangelisches Krankenhaus Hamm, Hamm, Germany.
  • Meyer A; Department of Pneumology, Maria Hilf Hospital, Moenchengladbach, Germany.
  • Ladage D; Department of Pneumology, Maria Hilf Hospital, Moenchengladbach, Germany.
  • Geissler M; Esslingen Cancer Center Department of Oncology, Gastroenterology and Infectious Diseases Klinikum Esslingen, Esslingen, Germany.
  • Colantonio I; Division of Oncology, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy.
  • Cauchi C; Division of Oncology, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy.
  • Stoelben E; Lung Clinic, Cologne-Merheim Hospital, Cologne, Germany.
  • Ceribelli A; Division of Clinical Oncology A, Istituto Nazionale Regina Elena per lo Studio e la Cura dei Tumori, Rome, Italy.
  • Kropf-Sanchen C; Department of Pulmonology, Internal Medicine II, University of Ulm, Ulm, Germany.
  • Valmadre G; Division of Clinical Oncology, Ospedale di Sondalo, Sondrio, Italy.
  • Borra G; Division of Clinical Oncology, AOU Maggiore della Carità, Novara, Italy.
  • Schena M; Division of Clinical Oncology I, AOU Città della Salute e della Scienza, Turin, Italy.
  • Morabito A; Division of Clinical Oncology and Thoracic Pneumology, IRCCS Fondazione Pascale, Naples, Italy.
  • Santo A; Complex Operative Unit of Oncology - Gruppo Interdisciplinare Veronese Oncologia Polmonare (GIVOP), Verona, Italy.
  • Gregorc V; Division of Clinical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Chiari R; Division of Clinical Oncology, Azienda Ospedaliera di Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy.
  • Reck M; Oncology Department, LungenClinic Grosshansdorf, Grosshansdorf, Germany.
  • Schmid-Bindert G; Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Folprecht G; University Hospital Carl Gustav Carus Medical Department I Dresden, Dresden, Germany.
  • Griesinger F; Clinic for Haematology and Oncoloy, Medizinischer Campus Universität Oldenburg, Oldenburg, Germany.
  • Follador A; Department of Oncology, Presidio Ospedaliero Universitario Santa Maria della Misericordia, Azienda Sanitaria Universitaria Integrata Friuli Centrale, Udine, Italy.
  • Pedrazzoli P; Medical Oncology, Fondazione IRCCS Policlinico S. Matteo and Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.
  • Bearz A; Division of Clinical Oncology, Centro di Riferimento Oncologico, Aviano, Italy.
  • Caffo O; Division of Clinical Oncology, Ospedale Santa Chiara, Trento, Italy.
  • Dickgreber NJ; Department for Respiratory Medicine and Thoracic Oncology, Klinikum Rheine - Mathias-Spital, Rheine, Germany.
  • Irtelli L; Oncology Clinic, Policlinico SS. Annunziata, Chieti, Italy.
  • Wiest G; Asklepios Cancer Center Hamburg, Asklepios Klinikum Harburg, Hamburg, Harburg, Germany.
  • Monica V; University of Torino, Department of Oncology at San Luigi Hospital, Orbassano (Torino), Italy.
  • Porcu L; Laboratory of Methodology for Clinical Research, Oncology Department at Instituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Manegold C; Department of Surgery, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
  • Scagliotti GV; University of Torino, Department of Oncology at San Luigi Hospital, Orbassano (Torino), Italy.
Ann Oncol ; 33(4): 454, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35086737
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Clinical_trials Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Clinical_trials Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article